Companies / Travere Therapeutics, Inc. / Activity

Activity — Travere Therapeutics, Inc.

14 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
RA Capital Management, L.P.
13F manager
NewCommon stock$22.19M+747K
746,841
0.79% of shares
medium
Q1 2026
as of
Schroder Investment Management Group
13F manager
NewCommon stock$5.94M+215K
214,925
0.23% of shares
medium
Q1 2026
as of
Capital Fund Management S.A.
13F manager
NewCommon stock$2.55M+86K
85,881
0.09% of shares
low
Q2 2026
as of
JW Asset Management, LLC
13F manager
NewCommon stock$1.70M+30K
30,000
0.03% of shares
low
Q1 2026
as of
HighVista Strategies LLC
13F manager
NewCommon stock$1.08M+36K
36,325
0.04% of shares
low
Q2 2026
as of
Quadrature Capital Ltd
13F manager
NewCommon stock$983.5K+17K
17,312
0.02% of shares
low
Q1 2026
as of
TD Asset Management Inc
13F manager
NewCommon stock$520.9K+18K
17,534
0.02% of shares
low
Q3 2025
as of
Farallon Capital Management LLC
13F manager
NewCommon stock$286.8K+12K
12,000
0.01% of shares
low
Q1 2026
as of
Css LLC/IL
13F manager
NewCommon stock$221.9K+7K
7,470
<0.01% of shares
low
Q2 2026
as of
OneDigital Investment Advisors LLC
13F manager
NewCommon stock$220.0K+4K
3,872
<0.01% of shares
low
Q1 2026
as of
Hudson Bay Capital Management LP
13F manager
NewCommon stock$193.7K+7K
6,520
<0.01% of shares
low
Q4 2025
as of
Persistent Asset Partners Ltd
13F manager
NewCommon stock$125.7K+3K
3,291
<0.01% of shares
low
Q1 2026
as of
Eastern Bank
13F manager
NewCommon stock$9.7K+325
325
<0.01% of shares
low
Q4 2025
as of
Evolution Wealth Management Inc.
13F manager
NewCommon stock$3.8K+100
100
<0.01% of shares
low
← PrevPage 1 of 1Next →